Rafael Statistics
NYSE: RFLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9197+0.0197 (+2.19%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Rafael by the numbers
Rafael has a market capitalization of $48.0 million based on 51.39M shares outstanding. With trailing EPS of $-0.58, Rafael is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.5% below its 50-day average and 44.9% below its 200-day average.
Average daily trading volume is 140.84K shares, or about $129,530 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RFL valuation vs. peer median
| Metric | RFL | Peer median | Difference |
|---|---|---|---|
| Market cap | $47.99M | $47.11M | +2% |
| Avg. volume | 140.84K | 957.84K | -85% |
Peer median across 8 companies: HRTX, ONCY, NMAD, VRCA, ACRV, TNXP, MIST, HOWL.
Valuation
- Market cap
- $47.99M
- Price / sales (latest FY)
- 54.90
- EPS (TTM)
- $-0.58
- Shares outstanding
- 51.39M
Price and trading
- Previous close
- 0.90
- Open
- 0.781
- Day range
- 0.8001 – 0.9691
- 52-week range
- 0.781 – 3.96
- 52-week change
- -25.83%
- Beta
- —
- Volume
- 156.49K
- Average volume
- 140.84K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 10, 2026
Additional statistics
- Market Cap
- 47.99M
- Eps
- -0.58
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.96
- Week52 Low
- 0.78
- Avg Volume
- 140.84K
- Shares Outstanding
- 51.39M
- Ma50
- 1.43
- Ma200
- 1.67
- Earnings Date
- Dec 10, 2026
- Pct From52w High
- -76.78%
- Pct From52w Low
- 17.76%